Sign in

CIK 0001785530

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Werewolf Therapeutics, Inc.

Sign in to watch
Ticker
HOWL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
823523180
Phone
+1 617-952-0555
Business address
303 WYMAN STREET, SUITE 300, WALTHAM, MA, 02451
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2025-11-14 EVNIN LUKE Director Sale 10b5-1 −39,560 $0.93 $37K 3,552,501
2025-11-13 MPM BioVentures 2014, L.P. 10% owner Sale 10b5-1 −90,951 $0.98 $89K 5,600,240
2025-11-13 GADICKE ANSBERT 10% owner Sale 10b5-1 −90,951 $0.98 $89K 5,600,240
2025-11-13 EVNIN LUKE Director Sale 10b5-1 −58,372 $0.98 $57K 3,592,061
2025-11-12 MPM BioVentures 2014, L.P. 10% owner Sale 10b5-1 −40,669 $1.09 $44K 5,691,191
2025-11-12 GADICKE ANSBERT 10% owner Sale 10b5-1 −40,669 $1.09 $44K 5,691,191
2025-11-12 EVNIN LUKE Director Sale 10b5-1 −26,101 $1.09 $28K 3,650,433
2025-11-11 MPM BioVentures 2014, L.P. 10% owner Sale 10b5-1 −55,810 $1.14 $64K 5,731,860
2025-11-11 GADICKE ANSBERT 10% owner Sale 10b5-1 −55,810 $1.14 $64K 5,731,860
2025-11-11 EVNIN LUKE Director Sale 10b5-1 −35,818 $1.14 $41K 3,676,534
2025-11-10 MPM BioVentures 2014, L.P. 10% owner Sale 10b5-1 −48,570 $1.18 $57K 5,787,670
2025-11-10 GADICKE ANSBERT 10% owner Sale 10b5-1 −48,570 $1.18 $57K 5,787,670
2025-11-10 EVNIN LUKE Director Sale 10b5-1 −31,172 $1.18 $37K 3,712,352
2025-11-07 MPM BioVentures 2014, L.P. 10% owner Sale 10b5-1 −68,480 $1.11 $76K 5,836,240
2025-11-07 GADICKE ANSBERT 10% owner Sale 10b5-1 −68,480 $1.11 $76K 5,836,240
2025-11-07 EVNIN LUKE Director Sale 10b5-1 −43,950 $1.11 $49K 3,743,524
2025-11-06 MPM BioVentures 2014, L.P. 10% owner Sale 10b5-1 −54,452 $1.21 $66K 5,904,720
2025-11-06 GADICKE ANSBERT 10% owner Sale 10b5-1 −54,452 $1.21 $66K 5,904,720
2025-11-06 EVNIN LUKE Director Sale 10b5-1 −34,947 $1.21 $42K 3,787,474
2025-11-05 MPM BioVentures 2014, L.P. 10% owner Sale 10b5-1 −47,950 $1.22 $58K 5,959,172

Page 7 of 17 · 335 trades